Simtra Opens $250 Million Building H in Bloomington as Hiring Ramps Toward 300

Simtra BioPharma Solutions on Monday unveiled a $250 million, 140,000-square-foot manufacturing facility in Bloomington, Indiana, where employees will earn about $35 per hour on average. Yahoo reported the opening of the plant, called Building H.

Inside Simtra's Building H in Bloomington

Simtra BioPharma Solutions is a privately held contract manufacturer of sterile injectables, filling syringes and vials for pharmaceutical and biotech clients. The new plant employs about 100 people, and Patrick J. Adams, vice president of expansion operations, said he expects about 300 employees in the building at the end of next year. That would bring Simtra's Bloomington employment near 2,000.

The company's website on Monday afternoon listed 70 job openings in Bloomington, including in supply chain, production, maintenance and engineering. Production workers earn about $25.77 per hour on average, or about $54,000 per year, while some salaried employees earn more than $100,000.

Adams said Building H marks "a major expansion of our Bloomington manufacturing campus and a very important milestone of Simtra's overall journey of growth." The facility contains new production lines for prefilled syringes and injectable medications packaged in vials. The Bloomington site already runs around the clock in three shifts and produces about 130 million products annually, of which about 100 million are syringes.

Gov. Mike Braun thanked Simtra's leaders for "believing in our state," and Bloomington Mayor Kerry Thomson said the medicines made there help patients across the country and around the world.

Simtra's Recent Expansion Spending

According to akta.pro company records, Simtra announced a $100+ million expansion of its Halle/Westfalen, Germany facility in October 2025 to add syringe manufacturing capacity and additional vial capacity. In July 2025 the company purchased a 65-acre property with over 300,000 square feet of available space near its Bloomington facility for future high-potency drug manufacturing. The same records list recent investments of over $350 million, including the $250 million-plus Bloomington expansion and the $100 million-plus Halle project.

How Simtra Reached the Bloomington Opening

In May 2026, SCW.AI and Simtra announced a co-innovation partnership to modernize their Bloomington and Halle factories using SCW.AI's Digital Factory Platform, EIN Presswire reported. At World ADC San Diego in September 2026, Simtra's CCO Mike Schaefers noted a pipeline of over 3,300 ADCs and expected about 20 FDA submissions in 2026-2027, according to a company LinkedIn post. PR Newswire reported on November 9, 2026, that Simtra opened Building H, a 153,000-square-foot facility adding prefilled syringe, vial and lyophilization capabilities.

Simtra's Next Site Near Bloomington

Simtra last year spent $45 million to buy a 65-acre property from Cook Group at 301 N. Curry Pike and is spending hundreds of millions of dollars to rehab the facility and install new production lines. Adams said the former Cook facility is expected to begin operations in a little over a year, and company officials said the campus has the potential to be three times the size of Building H.